MARKET

NTUS

NTUS

Natus Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.90
0.00
0.00%
Opening 11:36 08/12 EDT
OPEN
18.11
PREV CLOSE
17.90
HIGH
18.12
LOW
17.62
VOLUME
50.52K
TURNOVER
--
52 WEEK HIGH
34.89
52 WEEK LOW
17.37
MARKET CAP
606.30M
P/E (TTM)
-259.0449
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NTUS stock price target is 36.00 with a high estimate of 36.00 and a low estimate of 36.00.

EPS

NTUS News

More
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 08/02 15:45
Natus Medical Incorporated (NTUS) Q2 2020 Earnings Call Transcript
MotleyFool.com · 07/31 06:31
Natus Medical Q2 EPS $(0.13) May Not Compare To $0.72 Estimate, Sales $84.80M Miss $98.20M Estimate
Natus Medical (NASDAQ:NTUS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $0.72 by 118.06 percent. This is a 138.24 percent decrease over earnings of $0.34 per share from
Benzinga · 07/30 20:12
Natus Medical Announces Second Quarter 2020 Financial Results
Q2-2020 Key Results Revenue (millions)$84.8 • Newborn Care revenue increased 1% compared to second quarter last year • Reduced debt by $13.0 million during the quarter  • NICVIEW II released during the quarter GAAP loss per share$0.26  Non-GAAP loss per
GlobeNewswire · 07/30 20:01
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)
Benzinga · 07/30 12:09
Natus Medical EPS beats by $0.08, misses on revenue
Seeking Alpha · 07/30 04:00
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Benzinga · 07/26 13:55
White Brook Capital LLC Q2 2020 Commentary
Seeking Alpha - Article · 07/24 16:15

Industry

Advanced Medical Equipment & Technology
+1.74%
Healthcare Equipment & Supplies
+1.64%

Hot Stocks

Symbol
Price
%Change

About NTUS

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.
More

Webull offers kinds of Natus Medical Inc stock information, including NASDAQ:NTUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTUS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTUS stock methods without spending real money on the virtual paper trading platform.